Provider
QP98-22 Commercial Pharmacy Benefit Exclusion for Cimerli™, Skysona®, Spevigo®, and Xenpozyme™
Program effective Date: Nov 23, 2022
Search Results
Displaying 1131 - 1140 of 4179 results
Provider
QP97-22 Update for New to Market Medical Drugs: etranacogene dezaparvovec
Program effective Date: Nov 23, 2022
Provider
QP100-22 Service Area Expansion for Minnesota Health Care Programs (MHCP)
Program effective Date: Nov 23, 2022
Provider
P25R1-20 Children’s Therapeutic Services and Supports (CTSS) Prior Authorization Requirement
Program effective Date: Feb 01, 2023
Provider
QP112R1-20 Changes to Electronic Funds Transfer Processes
Program effective Date: Feb 22, 2023
Provider
QP11-23 Commercial Pharmacy Benefit Exclusion for Cimzia®
Program effective Date: Feb 22, 2023
Provider
QP12-23 Change in Prior Authorization Process for Experimental or Investigative Services
Program effective Date: Feb 22, 2023
Provider
QP6-23 Commercial Pharmacy Benefit Exclusion for Briumvi™, Hemgenix®, Rebyota™, and Sunlenca® Injection
Program effective Date: Feb 08, 2023